NOX4 and neoplasm: The NOX4-driven system of endogenous ROS production demonstrates a new mechanism in OC cells to promote tumor development, angiogenesis, and an increase in therapeutic resistance through the upregulation of HER3, reflecting a candidate for targeted therapy of treatment-resistant OC (Figure 2).